USA Buys 3x More Antivirals From $PFE Than $MRK

USA Buys 3x More Antivirals From Pfizer Than Merck The Biden administration is planning to purchase 10 million courses of Pfizer’s covid pill https://www.washingtonpost.com/health/2021/11/16/administration-purchases-pfizer-anti-covid-pill/ That’s 3x more than Merck (3.1 million courses) With these exercised options, the U.S. government has now committed to purchase a total of approximately 3.1 million courses of molnupiravir, for approximately $2.2 billion https://www.merck.com/news/merck-and-ridgeback-announce-u-s-government-to-purchase-1-4-million-additional-courses-of-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-mild-to-moderate-covid-19-in-a/ This is complete dominance by Pfizer. Read more DD below. Pfizer Corners US and EU Markets Now Germany join France as Pfizer only. Germany recommends only Pfizer-Biontech COVID-19 vaccine for people under 30 https://www.channelnewsasia.com/world/germany-recommends-only-pfizer-biontech-covid-19-vaccine-people-under-30-2303691 France was first to go Pfizer only. French health authority advises against Moderna COVID-19 vaccine for under 30s PARIS, Nov 9 (Reuters) - France's public health authority has recommended people under 30 be given Pfizer's (PFE.N) Comirnaty COVID-19 vaccine when available instead of Moderna Inc's (MRNA.O) Spikevax jab, which carried comparatively higher risks of heart-related problems. https://www.reuters.com/business/healthcare-pharmaceuticals/french-health-authority-advises-against-moderna-covid-19-vaccine-under-30s-2021-11-09/ Pfizer eats Moderna’s lunch Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market. https://www.barrons.com/articles/moderna-vaccine-sales-earnings-miss-forecasts-51636027353 They take the EU next!!! Ramping Up Its COVID Response, EU Will Buy Up To 1.8B Doses Of Pfizer Vaccine https://www.npr.org/sections/coronavirus-live-updates/2021/05/08/995007124/ramping-up-its-covid-response-eu-will-buy-up-to-1-8b-doses-of-pfizer-vaccine Pfizer now 6th top stock held by congress. The Most Popular Stocks Owned by Congress https://investinganswers.com/articles/10-most-popular-stocks-owned-congress Also Pfizer first to market for kids vaccines. Big, as these kids will grow up on Pfizer. CDC recommends Pfizer's Covid-19 vaccine for kids 5 to 11 https://www.cnn.com/us/live-news/cdc-covid-vaccine-kids-02-11-21/index.html Also the best COVID antiviral pill on market is owned by Pfizer, showing much better efficacy than Merck’s COVID antiviral pill. Those orders go to Pfizer. Pfizer says COVID-19 pill cut hospital, death risk by 90% https://apnews.com/article/coronavirus-pandemic-science-business-health-medication-eeea3c6a5f6428479e35bc1bcd7aec52 Calculations Show Pfizer FY2022 Top Line 120B+, 50% Higher Than Current Guidance Pfizers guide for 2022 is 1.7 billion doses. See slide 35. https://investors.pfizer.com/investors-overview/default.aspx But if you notice, they are manufacturing 4 billion doses. That's means pfizer expects all these countries to execute the options on their contract for bi-annual boosters. This is just like the option the EU has on the contract below. https://www.npr.org/sections/coronavirus-live-updates/2021/05/08/995007124/ramping-up-its-covid-response-eu-will-buy-up-to-1-8b-doses-of-pfizer-vaccine That means pfizers actual vaccine sales will double current guidance, and revenue will be 120B for FY2022 and beyond. FY2021 REVENUE = 40B (VACCINE) + 40B (OTHER) = 80B https://www.investopedia.com/pfizer-q3-fy2021-earnings-report-recap-5208079 FY2022 REVENUE = 80B (VACCINE) + 40B (OTHER) = 120B Note: This estimate does not include antivirals, estimated up to 25b in 2022 sales. Barclays estimates Pfizer could draw $15B-25B in 2022 sales of #covid19 antiviral drug, "if pricing holds between $300-500/course and 90%+ of doses are distributed." https://twitter.com/megtirrell/status/1460709210430267400?s=2 It's all because the virus reinfects quickly, and repeatedly. Unvaccinated People Likely to Catch COVID Repeatedly https://www.webmd.com/vaccines/covid-19-vaccine/news/20211024/unvaccinated-people-likely-to-catch-covid-repeatedly I predicted this my DD 300 days ago ”Vaccine boosters needed bi-annually" https://www.reddit.com/r/wallstreetbets/comments/ljda9r/vaccine_boosters_needed_biannually/ The FDA is expected to clear boosters for all age 18+ and 6+ months vaccinated this weekend. Booster shots could be available to all adults by weekend https://www.msn.com/en-us/news/us/pfizer-requests-authorization-for-covid-pill-will-share-with-poorer-nations-vaccinated-can-feel-good-about-holidays-fauci-says-updates/ar-AAQLoec BNTX PFE are clear home runs. They are crushing all competition including Moderna. And they are going to raise guidance when these countries execute their options. Load to tits. Pfizer 🚀🚀🚀 PFE 64 PT 😂😂😂🚀🚀🚀🚀 Jan 2024 30c

back
scot-tagscot-icon

Iknowmorethanyou2

Nov 17, 2021

3.57%

Change % Since Posting

49.60

Price When Posted

1.77

Change Since Posting

Is this your Reddit account?

Claim this username to collect earnings from this post, and the portfolio!

portfolio reddit logoportfolio utradea logo

USA Buys 3x More Antivirals From $PFE Than $MRK

bullish

USA Buys 3x More Antivirals From Pfizer Than Merck

The Biden administration is planning to purchase 10 million courses of Pfizer’s covid pill

https://www.washingtonpost.com/health/2021/11/16/administration-purchases-pfizer-anti-covid-pill/

That’s 3x more than Merck (3.1 million courses)

With these exercised options, the U.S. government has now committed to purchase a total of approximately 3.1 million courses of molnupiravir, for approximately $2.2 billion

https://www.merck.com/news/merck-and-ridgeback-announce-u-s-government-to-purchase-1-4-million-additional-courses-of-molnupiravir-an-investigational-oral-antiviral-medicine-for-the-treatment-of-mild-to-moderate-covid-19-in-a/

This is complete dominance by Pfizer. Read more DD below.

Pfizer Corners US and EU Markets

Now Germany join France as Pfizer only.

Germany recommends only Pfizer-Biontech COVID-19 vaccine for people under 30

https://www.channelnewsasia.com/world/germany-recommends-only-pfizer-biontech-covid-19-vaccine-people-under-30-2303691

France was first to go Pfizer only.

French health authority advises against Moderna COVID-19 vaccine for under 30s

PARIS, Nov 9 (Reuters) - France's public health authority has recommended people under 30 be given Pfizer's (PFE.N) Comirnaty COVID-19 vaccine when available instead of Moderna Inc's (MRNA.O) Spikevax jab, which carried comparatively higher risks of heart-related problems.

https://www.reuters.com/business/healthcare-pharmaceuticals/french-health-authority-advises-against-moderna-covid-19-vaccine-under-30s-2021-11-09/

Pfizer eats Moderna’s lunch

Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

https://www.barrons.com/articles/moderna-vaccine-sales-earnings-miss-forecasts-51636027353

They take the EU next!!!

Ramping Up Its COVID Response, EU Will Buy Up To 1.8B Doses Of Pfizer Vaccine

https://www.npr.org/sections/coronavirus-live-updates/2021/05/08/995007124/ramping-up-its-covid-response-eu-will-buy-up-to-1-8b-doses-of-pfizer-vaccine

Pfizer now 6th top stock held by congress.

The Most Popular Stocks Owned by Congress

https://investinganswers.com/articles/10-most-popular-stocks-owned-congress

Also Pfizer first to market for kids vaccines. Big, as these kids will grow up on Pfizer.

CDC recommends Pfizer's Covid-19 vaccine for kids 5 to 11

https://www.cnn.com/us/live-news/cdc-covid-vaccine-kids-02-11-21/index.html

Also the best COVID antiviral pill on market is owned by Pfizer, showing much better efficacy than Merck’s COVID antiviral pill. Those orders go to Pfizer.

Pfizer says COVID-19 pill cut hospital, death risk by 90%

https://apnews.com/article/coronavirus-pandemic-science-business-health-medication-eeea3c6a5f6428479e35bc1bcd7aec52

Calculations Show Pfizer FY2022 Top Line 120B+, 50% Higher Than Current Guidance

Pfizers guide for 2022 is 1.7 billion doses. See slide 35.

https://investors.pfizer.com/investors-overview/default.aspx

But if you notice, they are manufacturing 4 billion doses. That's means pfizer expects all these countries to execute the options on their contract for bi-annual boosters. This is just like the option the EU has on the contract below.

https://www.npr.org/sections/coronavirus-live-updates/2021/05/08/995007124/ramping-up-its-covid-response-eu-will-buy-up-to-1-8b-doses-of-pfizer-vaccine

That means pfizers actual vaccine sales will double current guidance, and revenue will be 120B for FY2022 and beyond.

FY2021 REVENUE = 40B (VACCINE) + 40B (OTHER) = 80B

https://www.investopedia.com/pfizer-q3-fy2021-earnings-report-recap-5208079

FY2022 REVENUE = 80B (VACCINE) + 40B (OTHER) = 120B

Note: This estimate does not include antivirals, estimated up to 25b in 2022 sales.

Barclays estimates Pfizer could draw $15B-25B in 2022 sales of #covid19 antiviral drug, "if pricing holds between $300-500/course and 90%+ of doses are distributed."

https://twitter.com/megtirrell/status/1460709210430267400?s=2

It's all because the virus reinfects quickly, and repeatedly.

Unvaccinated People Likely to Catch COVID Repeatedly

https://www.webmd.com/vaccines/covid-19-vaccine/news/20211024/unvaccinated-people-likely-to-catch-covid-repeatedly

I predicted this my DD 300 days ago

”Vaccine boosters needed bi-annually"

https://www.reddit.com/r/wallstreetbets/comments/ljda9r/vaccine_boosters_needed_biannually/

The FDA is expected to clear boosters for all age 18+ and 6+ months vaccinated this weekend.

Booster shots could be available to all adults by weekend

https://www.msn.com/en-us/news/us/pfizer-requests-authorization-for-covid-pill-will-share-with-poorer-nations-vaccinated-can-feel-good-about-holidays-fauci-says-updates/ar-AAQLoec

BNTX PFE are clear home runs. They are crushing all competition including Moderna. And they are going to raise guidance when these countries execute their options. Load to tits.

Pfizer 🚀🚀🚀

PFE 64 PT 😂😂😂🚀🚀🚀🚀

Jan 2024 30c

Comments

Write your comment....

Sign in to comment

read-time
3 min

64.00

Target Price

9/ 10

Confidence

2-6 Months

Timeframe
Share
catalyst icon
Earnings Release
catalyst icon
News
catalyst icon
SEC Filing
catalyst icon
Sentiment
catalyst icon
Other Catalyst

PFE Channel

Start new chat
aiodd-ad
next